These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 10957937)

  • 1. Recent advances in the diagnosis and treatment of pediatric inflammatory bowel disease.
    Seidman EG
    Curr Gastroenterol Rep; 2000 Jun; 2(3):248-52. PubMed ID: 10957937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum.
    Markowitz J; Grancher K; Mandel F; Daum F
    Am J Gastroenterol; 1993 Jan; 88(1):44-8. PubMed ID: 8420272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discordant erythrocyte sedimentation rate and C-reactive protein in children with inflammatory bowel disease taking azathioprine or 6-mercaptopurine.
    Barnes BH; Borowitz SM; Saulsbury FT; Hellems M; Sutphen JL
    J Pediatr Gastroenterol Nutr; 2004 May; 38(5):509-12. PubMed ID: 15097439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Inflammatory bowel diseases (IBD) -- critical discussion of etiology, pathogenesis, diagnostics, and therapy].
    Ochsenkühn T; Sackmann M; Göke B
    Radiologe; 2003 Jan; 43(1):1-8. PubMed ID: 12552369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing thiopurine therapy in inflammatory bowel disease.
    Chevaux JB; Peyrin-Biroulet L; Sparrow MP
    Inflamm Bowel Dis; 2011 Jun; 17(6):1428-35. PubMed ID: 20949566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in inflammatory bowel diseases in children.
    Michail S; Ramsy M; Soliman E
    Minerva Pediatr; 2012 Jun; 64(3):257-70. PubMed ID: 22555319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limited risks of major congenital anomalies in children of mothers with IBD and effects of medications.
    Ban L; Tata LJ; Fiaschi L; Card T
    Gastroenterology; 2014 Jan; 146(1):76-84. PubMed ID: 24126096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressive drugs in the treatment of inflammatory bowel disease.
    Aranda R; Horgan K
    Semin Gastrointest Dis; 1998 Jan; 9(1):2-9. PubMed ID: 9547850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experiences with 6-mercaptopurine and azathioprine therapy in pediatric patients with severe ulcerative colitis.
    Kader HA; Mascarenhas MR; Piccoli DA; Stouffer NO; Baldassano RN
    J Pediatr Gastroenterol Nutr; 1999 Jan; 28(1):54-8. PubMed ID: 9890469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges and progress in pediatric inflammatory bowel disease.
    Rufo PA; Bousvaros A
    Curr Opin Gastroenterol; 2007 Jul; 23(4):406-12. PubMed ID: 17545777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of 6-mercaptopurine in patients with inflammatory bowel disease previously intolerant of azathioprine.
    Bowen DG; Selby WS
    Dig Dis Sci; 2000 Sep; 45(9):1810-3. PubMed ID: 11052324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring of azathioprine/6-mercaptopurine treatment in children with IBD is not necessary.
    Griffiths AM
    Inflamm Bowel Dis; 2003 Nov; 9(6):389-91; discussion 392-3. PubMed ID: 14671489
    [No Abstract]   [Full Text] [Related]  

  • 16. Combined use of cyclosporine and azathioprine or 6-mercaptopurine in pediatric inflammatory bowel disease.
    Ramakrishna J; Langhans N; Calenda K; Grand RJ; Verhave M
    J Pediatr Gastroenterol Nutr; 1996 Apr; 22(3):296-302. PubMed ID: 8708884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-aminosalicylate therapy is associated with higher 6-thioguanine levels in adults and children with inflammatory bowel disease in remission on 6-mercaptopurine or azathioprine.
    Hande S; Wilson-Rich N; Bousvaros A; Zholudev A; Maurer R; Banks P; Makrauer F; Reddy S; Burakoff R; Friedman S
    Inflamm Bowel Dis; 2006 Apr; 12(4):251-7. PubMed ID: 16633046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azathioprine: state of the art in inflammatory bowel disease.
    Sandborn WJ
    Scand J Gastroenterol Suppl; 1998; 225():92-9. PubMed ID: 9515759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thiopurine methyltransferase activity in inflammatory bowel disease. A study on 7046 Spanish patients].
    Gisbert JP; Gomollón F; Cara C; Luna M; González-Lama Y; Pajares JM; Maté J; Guijarro LG
    Med Clin (Barc); 2005 Sep; 125(8):281-5. PubMed ID: 16159550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current therapy of inflammatory bowel disease in children.
    Rufo PA; Bousvaros A
    Paediatr Drugs; 2006; 8(5):279-302. PubMed ID: 17037946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.